Engineering of primary metabolic pathways for titer improvement of milbemycins in Streptomyces bingchenggensis

Yuqing Liu,Haiyan Wang,Shanshan Li,Yanyan Zhang,Xu Cheng,Wensheng Xiang,Xiangjing Wang
DOI: https://doi.org/10.1007/s00253-021-11164-7
IF: 5
2021-02-10
Applied Microbiology and Biotechnology
Abstract:Milbemycins are used commercially as insect repellents and acaricides; however, their high cost remains a significant challenge to commercial production. Hence, improving the titer of milbemycins for commercial application is an urgent priority. The present study aimed to effectively increase the titer of milbemycins using a combination of genome re-sequencing and metabolic engineering. First, 133 mutation sites were identified by genome re-sequencing in the mutagenized high-yielding strain BC04. Among them, three modifiable candidate genes (<i>sbi_04868</i> encoding citrate synthase, <i>sbi_06921</i> and <i>sbi_06922</i> encoding alpha and beta subunits of acetyl-CoA carboxylase, and <i>sbi_04683</i> encoding carbon uptake system gluconate transporter) related to primary metabolism were screened and identified. Next, the DNase-deactivated Cpf1–based integrative CRISPRi system was used in <i>S. bingchenggensis</i> to downregulate the transcription level of gene <i>sbi_04868</i>. Then, overexpression of the potential targets <i>sbi_06921</i>-<i>06922</i> and <i>sbi_04683</i> further facilitated milbemycin biosynthesis. Finally, those candidate genes were engineered to produce strains with combinatorial downregulation and overexpression, which resulted in the titer of milbemycin A3/A4 increased by 27.6% to 3164.5 mg/L. Our research not only identified three genes in <i>S. bingchenggensis</i> that are closely related to the production of milbemycins, but also offered an efficient engineering strategy to improve the titer of milbemycins using genome re-sequencing.
biotechnology & applied microbiology
What problem does this paper attempt to address?
### Problems the Paper Aims to Solve The paper aims to increase the yield of milbemycins through genome resequencing and metabolic engineering methods. Milbemycins, as important commercial anthelmintics and acaricides, are widely used in agriculture and animal husbandry; however, their high cost limits large-scale production. Therefore, increasing the yield of milbemycins has become an urgent need. ### Main Research Content 1. **Genome Resequencing Analysis**: - Researchers performed genome resequencing on the high-yield strain BC04 and identified 133 mutation sites. - Among them, three candidate genes related to primary metabolic pathways were screened: sbi_04868 encoding citrate synthase, sbi_06921 and sbi_06922 encoding the α and β subunits of acetyl-CoA carboxylase, and sbi_04683 encoding the gluconate transporter protein of the carbon uptake system. 2. **CRISPRi System Application**: - The transcription level of sbi_04868 was downregulated using a CRISPRi-based DNase-deactivated Cpf1 integration system. - Overexpression of potential target genes sbi_06921-sbi_06922 and sbi_04683 further promoted the biosynthesis of milbemycins. 3. **Combinatorial Engineering Strategy**: - Ultimately, by combining the downregulation and overexpression of these candidate genes, the yield of milbemycin A3/A4 increased by 27.6%, reaching 3164.5 mg/L. ### Conclusion This paper not only identified three genes closely related to milbemycin production in the bacterium *S. bingchenggensis* of the Streptomyces genus but also proposed an effective engineering strategy to increase milbemycin yield using genome resequencing technology. This research provides new ideas and technical means for developing high-yield milbemycin strains.